Back to top

Quarterly Newsletter Q2 2024

In our second newsletter of the year, we are proud to announce our new enhanced mycoplasma testing service for cell cultures. From there, we'll introduce you to our next highly standardized NGS service, miCORE Resequencing, for comprehensive and cost-effective analysis of both prokaryotic and eukaryotic genomes. Finally, don’t miss our new white paper on GxP-compliant analytical testing of novel biological drugs, offering valuable insights and best practices.


Read the newsletter here!


Go back